Goldman Sachs
DCOY

Goldman Sachs’s Decoy Therapeutics DCOY Stock Holding History

Goldman Sachs’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-93
Closed -$14.9K – 6628
2025
Q2 		$14.9K Buy
+93
New +$13.1K ﹤0.01% 6000
2017
Q3 		– Hold
0
– -$87K – 6843
2017
Q2 		– Hold
0
– – – 6182
2017
Q1 		– Hold
0
– – – 6309
2016
Q4 		– Hold
0
– – – 6188
2016
Q3 		– Hold
0
– -$131K – 7169
2016
Q2 		– Hold
0
– – – 5987
2016
Q1 		– Hold
0
– – – 5374
2015
Q4 		– Hold
0
– – – 5744

Other funds holding DCOY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Goldman Sachs's DCOY Position: Q3 2025 in Review

Goldman Sachs sold out of Decoy Therapeutics (DCOY) in Q3 2025, closing a stake of 93 shares — an estimated $14.9K sold.

Goldman Sachs first reported a position in DCOY in Q2 2025 and held it in 1 quarter. The position peaked at $14.9K in Q2 2025. 3 funds tracked by Wall St. Rank hold DCOY as of Q3 2025.

  • Goldman Sachs reported no remaining Decoy Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Goldman Sachs sold 93 Decoy Therapeutics shares in Q3 2025, an estimated $14.9K.
  • Goldman Sachs first reported a position in Decoy Therapeutics in Q2 2025 and held it in 1 quarter.
  • Goldman Sachs's Decoy Therapeutics position peaked at $14.9K in Q2 2025.
  • 3 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q3 2025.

Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.